Who has invested in Neurolens?

No investors are named on the public record for Neurolens yet.

Neurolens Funding: $186M Raised, Series B (2022)

Neurolens funding overview

Neurolens is based in Toronto, Ontario, Canada. Neurolens has raised $186M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Neurolens runs through 2022; nothing later has been disclosed.

Neurolens at a glance

Total raised: $186M
Latest round: Series B
Latest round date: January 2022
Headquarters: Toronto, Ontario, Canada

Frequently asked about Neurolens funding

How much has Neurolens raised?: Neurolens has raised $186M in total disclosed funding across the rounds on record.
Who has invested in Neurolens?: No investors are named on the public record for Neurolens yet.
What was the latest Neurolens funding round?: The most recent disclosed round is a Series B, announced in January 2022.
Where is Neurolens based?: Neurolens is based in Toronto, Ontario, Canada.
When did Neurolens last raise?: The last disclosed Neurolens round closed in January 2022 at Series B.

Neurolens totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Toronto below to benchmark round size and investor mix.

Neurolens Funding: $186M Raised, Series B (2022)

Neurolens funding overview

Neurolens at a glance

Frequently asked about Neurolens funding

Companies related to Neurolens (18)

Browse related funding lists (5)